- Our Team
- For Patients
- Treatments & Services
- Medical Professionals
Hematology
Clinical Trial Search
Trial Protocol ID
XPORT-MF-044
Investigator
Mohit Narang, M.D.
A Phase 2 study to evaluate the efficacy and safety of selinexor monotherapy in subjects with JAK inhibitor (JAKi)-naïve myelofibrosis and moderate thrombocytopenia